A clinical trial on understanding sleep, cognition, autonomic and physical function in patients with chronic low back pain.

Studies on understanding and managing sleep, cognition, Autonomic and Physical function in patients with non-specific chronic low back pain - NIL

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101065

Enrollment

Registered

2026-01-14

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M999- Biomechanical lesion, unspecified

Interventions

Intervention1: modern neuroscience approach: Modern neuroscience intervention will be given along with conventonal treatment (hot pack, IFT and lumbar stabiliaztion exercises) Intervention2: Modern ne

Eligibility

Inclusion criteria

Inclusion criteria: Medical diagnosis of non-specific chronic low back pain (NCLBP) with pain and 2. symptoms persisting for longer than 3 months and lesser than 7 years in accordance with standard diagnostic criteria and prior research conventions (Airaksinen et al., 2006; Wand et al., 2011). 3. Age between 19 and 55 years (Heffner et al., 2011) 4. NPRS more than 3 and less than 7 (moderate pain intensity, which is clinically significant yet not severely limiting) 5. Both male and female 6. Participants with working knowledge of english language in order to complete the questionnaires. 7. Willing to participate in a structured exercise program 8. Willing to stay overnight for polysomnography

Exclusion criteria

Exclusion criteria: 1.History of spinal surgery (Uchmanowicz et al., 2018) 2. Spinal and lower limb deformities 3. Inflammatory joint disease 4. Traumatic spine and lower limb injuries 5. Pregnant women 6. History or evidence of cardiovascular disease (history of angina, myocardial infarction, shortness of breath, uncontrolled hypertension) (Bandeira et al., 2021) 7. Participants suffering from any diagnosed psychiatric, neurological or cognitive, systematic, medical diseases/disorders 8. Use of centrally active medications and sleep medications (Aldabbas et al., 2021) 9. Previously diagnosed and treated sleep disorders (Uchmanowicz et al., 2018)

Design outcomes

Primary

Measure	Time frame
PSQI Polysomnography P300 for cognition Heart rate variability testing Oswestry disability questionnaire Electromyography Pain pressure threshold FABQ TSK PCS Montreal Cognitive assessment Central Sensitization Inventory Sleep hygiene R U Sated Pittsburgh insomnia rated scale Timepoint: At baseline At 8 weeks At 12 weeks	—

Secondary

Measure	Time frame
NIL Timepoint: NIL	—

Countries

India

Contacts

Public ContactZubia Veqar

Jamia Millia Islamia

veqar.zubia@gmail.com995899386

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026